Track topics on Twitter Track topics that are important to you
Arachnova is a virtual R&D based pharmaceutical company and a pioneer of therapeutic switching (finding new therapeutic uses for existing drugs). Two important projects are in early stage clinical trials. The first is in stress urinary incontinence, the second in dermatitis — both potentially large but under-researched disease areas in need of better therapies.Therapeutic Switching — an opportunity for partnership
Arachnova has an unparalleled capability to find new uses for existing compounds, and has used this capability to generate its own patent-protected projects. It is based on a unique way of looking at drug discovery, on extensive partnerships with academic investigators and on SwitchBasetm, its proprietary database. SwitchBasetm is an exclusive database that links known compounds to potential new uses that are being discovered, for instance, from the company's own research and from the revelations of new biology. The benefit of this expertise and technology is offered to others in the pharmaceutical industry. Arachnova offers a no-fee evaluation on the basis that it is typically expected to produce patentable licence and/or development opportunities in partnership. Arachnova is in a position to take suitable projects through to clinical proof-of-principle with its own resources.
Experts in project leadership, evaluation and outsourcing
The experience of the team, their proven track record in successful R&D and bringing compounds speedily through clinical trials makes Arachnova a highly valuable partner.
Arachnova is expert at project leadership and outsourced project management. Retained as consultants to instigate and implement projects for a range of companies, work has encompassed all stages of the development process. The company's Technology Web(tm) is a vast database of service providers that can add value during the discovery and development process, and is available through www.arachnova.com/search.
Many clients and project partners are already reaping the benefits that this approach can bring — faster development times with lower costs and reduced risk. It is significant, and a testament to the capabilities of the Arachnova team, that clients regularly commission additional assignments. In addition to consultancy on project leadership and management Arachnova works in other areas including the provision of expert opinion, preparation of expert reports and the completion of due diligence projects.
St John's Innovation Centre
Phone: 44 1223 722793
Fax: 44 1223 722793
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...
MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
Arachnova has a focus on therapeutic switches, namely new uses for known drugs, and alternatively called 'drug reprofiling', 'drug repositioning' or 'drug repurposing'.Our approach is therapeutically ...
Arachnova is a virtual R&D based pharmaceutical company and a pioneer of therapeutic switching (finding new therapeutic uses for existing drugs). Two important projects are in early stage clinical tri...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
We have published hundreds of Arachnova Limited news stories on BioPortfolio along with dozens of Arachnova Limited Clinical Trials and PubMed Articles about Arachnova Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arachnova Limited Companies in our database. You can also find out about relevant Arachnova Limited Drugs and Medications on this site too.
Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...